By Nigam Arora & Dr. Natasha Arora

The Arora Report was giving buy signals on Ford (F) when almost everybody else was giving sell signals on Ford.   The average price of the Ford position is $6.61.  It is trading at $17.48 as of this writing representing a gain of 164%.

Chart

Please click here for the chart comparing the performance of Ford stock to Tesla (TSLA) stock.

Note the following:

  • The chart shows that Tesla stock has rocketed recently.
  • The chart shows that in spite of the big move up in Tesla stock, Ford stock has outperformed TSLA by about 57% year to date.
  • The chart shows that subscribers to The Arora Report have a 164% gain from the original Arora buy signal.

Earnings

Here are the key points:

  • Ford’s earnings were better than the consensus.
  • Ford’s earnings were significantly better than the whisper numbers.  Stocks move based on the difference between whisper numbers and the reported numbers.  Whisper numbers are the ones that analysts provide in private to their best clients. These numbers are kept confidential.
  • The company is positioning itself to compete with Tesla.
  • Ford is aggressively expanding electric vehicle production.
  • Ford is doubling production volume for the F-150 Lightning electric pickup truck.

Rivian

Here are the key points:

  • Rivian is an electrical vehicle company focused on autonomous vehicles.
  • Ford has an equity stake in  Rivian.
  • Rivian is planning an IPO.  Ford will have a significant gain if Rivian proceeds to IPO.
  • Rivian is expected to have valuation of about $80 billion.
  • In addition to Ford, Rivian is backed by Amazon (AMZN).
  • Amazon has already ordered 100,000 electric vans from Rivian.

 Zones

The low band of the target zone has been $18.  Ford stock is almost there.  The very long term target zone is being raised to 🔒 (To see the locked content, please take a 30 day free trial).

For those following the Good Way, the Buy Now rating is 🔒 to start a small scale in.

For those following the Best Way, the buy zone is  🔒.

The recommended quantity is 🔒 of full core position size.  To learn about full core position size, please see Trade Management Guidelines.

What To Do Now

Those in this stock may consider continuing to hold.

Those not in the stock may consider following the parameters given above.

Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007.   These trades have been scrutinized in real-time by thousands of investors across the globe.  This provides easy verification of performance for newcomers to this site.  Only those trades are included in the performance where the entry post was made available to subscribers to The Arora Report Market Blog.  When the entry post is made available only to the paying subscribers and not posted in real-time on The Arora Report Market Blog, the resulting performance of the trade is not credited in the performance table.  There are very nice gains on this trade but since the entry trade was not posted here for the free subscribers in real-time but only made available to the paying subscribers, handsome profits on this trade will not be added to the performance of The Arora Report Market Blog shown on the table.

To take a free 30-day trial to paid services to gain access to more opportunities, please click here.

This post was just published on ZYX Buy Change Alert.

Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES,
TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Nigam Arora

Nigam Arora

Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora

Dr. Natasha Arora

Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.